Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia
Status:
Completed
Trial end date:
2020-06-18
Target enrollment:
Participant gender:
Summary
To see if megestrol acetate plus Levonorgestrel-releasing intrauterine system (LNG-IUS) will
not be inferior to returning the endometrial tissue to a normal state than megestrol acetate
or LNG-IUS alone in patients with endometrial atypical hyperplasia.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Fudan University
Collaborators:
Shanghai 6th People's Hospital Shanghai Changning Maternity & Infant Health Hospital Zhejiang Cancer Hospital